leadf
logo-loader
viewAethlon Medical Inc

Aethlon Medical soars after FDA fast-tracks its virus treatment device

The FDA fast-track program was established to speed up patient access to breakthrough technologies with the potential to address life threatening diseases for which no approved treatment alternatives exist

Blood sample
The Hemopurifier is a single-use device indicated for the treatment of life-threatening viruses

Shares in Aethlon Medical Inc (NASDAQ:AEMD) soared as the therapeutic technology company received a green light from the US Food and Drug Administration (FDA).

The shares rose 70% to US$3.39 after the company said the FDA had issued an Expedited Access Pathway (EAP) designation to support the advancement of Aethlon’s Hemopurifier device to treat life-threatening viruses.

The designation means the device will be fast-tracked through the regulatory process.

The Hemopurifier is a single-use device indicated for the treatment of life-threatening viruses that are not addressed with an approved treatment.

To date, the Hemopurifier has been validated The FDA approved Aethlon’s “indicated for use” application, meaning that rather than be used for a single disease condition, it can be used to capture a broad-spectrum of viruses, including life-threatening strains of pandemic influenza viruses, mosquito-borne viruses as well as haemorrhagic viruses that are not addressed with an approved treatment.

Quick facts: Aethlon Medical Inc

Price: 1.82 USD

NASDAQ:AEMD
Market: NASDAQ
Market Cap: $22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

FansUnite Entertainment pleased Canada taking a look at allowing single...

FansUnite Entertainment (CSE: FANS- OTCQB: FUNFF) President Darius Eghdami joined Steve Darling from Proactive with news the company is hailing the Canadian government’s decision to introduce legislation that would legalize single-event sports betting in Canada. Eghdami talks about why that...

1 hour ago

2 min read